ストックスクリーナーアプリを入手
2.39
0.42%
-0.010
アフターアワーズ：
2.39
前日終値:
$2.40
開ける：
$2.41
24時間の取引高:
113.42K
Relative Volume:
1.10
時価総額：
$98.00M
収益：
$2.70M
当期純損益:
$5.53M
株価収益率:
21.73
EPS:
0.11
ネットキャッシュフロー:
$-10.55M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-9.47%
6か月 パフォーマンス:
+3.02%
1年 パフォーマンス:
+0.42%
1日の値動き範囲:
$2.32
$2.41
1週間の範囲:
$2.30
$2.43
52週間の値動き範囲:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
名前
Oramed Pharmaceuticals Inc
セクター
電話
646-844-1164
住所
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
ORMP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.39 | 98.41M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-01-12 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-04-20 | 開始されました | Canaccord Genuity | Buy |
| 2021-02-09 | 開始されました | National Securities | Buy |
| 2020-12-03 | 開始されました | Alliance Global Partners | Buy |
| 2020-03-11 | 開始されました | Aegis Capital | Buy |
| 2019-09-11 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-12-11 | 再開されました | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | 繰り返されました | FBR Capital | Outperform |
| 2015-12-01 | 繰り返されました | H.C. Wainwright | Buy |
| 2015-11-19 | 開始されました | FBR Capital | Outperform |
| 2015-04-13 | 再開されました | MLV & Co | Buy |
| 2014-01-30 | 繰り返されました | Aegis Capital | Buy |
| 2014-01-08 | 繰り返されました | Aegis Capital | Buy |
| 2014-01-08 | 開始されました | MLV & Co | Buy |
| 2013-12-03 | 開始されました | Aegis Capital | Buy |
すべてを表示
Oramed Pharmaceuticals Inc (ORMP) 最新ニュース
Why Oramed Pharmaceuticals Inc. stock is a must watch in 20252025 Valuation Update & Community Supported Trade Ideas - newser.com
Is Oramed Pharmaceuticals Inc a good long term investmentMoving Average Strategies & Superior Growth Investment - earlytimes.in
Is Oramed Pharmaceuticals Inc. stock a defensive play in 20252025 Geopolitical Influence & Community Consensus Trade Signals - newser.com
Ranking Oramed Pharmaceuticals Inc. among high performing stocks via toolsPortfolio Return Report & Weekly Market Pulse Updates - newser.com
Pattern recognition hints at Oramed Pharmaceuticals Inc. upsideQuarterly Profit Review & Detailed Earnings Play Alerts - newser.com
What does recent volatility data suggest for Oramed Pharmaceuticals Inc.July 2025 Closing Moves & Free High Return Stock Watch Alerts - newser.com
Why Oramed Pharmaceuticals Inc. (OJU1) stock fits value portfolios2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Using Ichimoku Cloud for Oramed Pharmaceuticals Inc. technicalsWeekly Profit Report & Verified Stock Trade Ideas - newser.com
Will Oramed Pharmaceuticals Inc. benefit from macro trends2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com
How Oramed Pharmaceuticals Inc. stock reacts to global recession fearsMarket Activity Report & Weekly Chart Analysis and Guides - newser.com
Will Oramed Pharmaceuticals Inc. (OJU1) stock maintain strong growthEarnings Miss & Real-Time Volume Trigger Notifications - newser.com
Applying sector rotation models to Oramed Pharmaceuticals Inc.July 2025 Review & Weekly High Potential Alerts - newser.com
Is Oramed Pharmaceuticals Inc. (OJU1) stock resilient in recession scenariosWeekly Volume Report & Growth Focused Investment Plans - newser.com
Custom watchlist performance reports with Oramed Pharmaceuticals Inc.Weekly Volume Report & Real-Time Volume Trigger Notifications - newser.com
Can technical indicators confirm Oramed Pharmaceuticals Inc.’s reversal2025 Price Action Summary & AI Driven Price Forecasts - newser.com
What recovery options are there for Oramed Pharmaceuticals Inc.July 2025 Analyst Calls & High Yield Equity Trading Tips - newser.com
Will Oramed Pharmaceuticals Inc. stock continue upward momentumEarnings Miss & Real-Time Sentiment Analysis - newser.com
Will breakout in Oramed Pharmaceuticals Inc. lead to full recoveryJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Tools to assess Oramed Pharmaceuticals Inc.’s risk profileJuly 2025 Technicals & High Conviction Buy Zone Alerts - newser.com
Oramed Pharm Repurchases Shares, Ends Joint Venture - MSN
Why Oramed Pharmaceuticals Inc. stock remains undervaluedPortfolio Risk Summary & Growth Focused Stock Reports - newser.com
Oramed Pharmaceuticals (ORMP) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Visualizing Oramed Pharmaceuticals Inc. stock with heatmapsQuarterly Profit Review & Low Risk Entry Point Guides - newser.com
Oramed Pharmaceuticals Inc (ORMP) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):